Serum histamine in Alzheimer's disease and multi-infarct dementia. 1992

R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
Department of Human Physiology, Complutense University Medical School, Madrid, Spain.

Recent data indicate that a neuroimmune reaction might be responsible in part for neuronal death and cognitive deterioration in senile dementia. The potential involvement of brain histamine (HA) and interleukin-1 (IL-1) in this process has been previously documented. We have studied the concentration of serum HA in patients with Alzheimer's disease (AD) or multi-infarct dementia (MID) and in age-matched control subjects. Serum HA levels were significantly higher in AD (10.935 +/- 5.692 nM) and MID (8.521 +/- 3.44 nM) than in controls (5.533 +/- 2.567 nM) and correlated with mental performance as evaluated with the Mini-Mental State Examination (MMSE) (r = +0.493, p < 0.009). No correlation was found with cardiovascular parameters, cerebrovascular risk factors or age. Hyperactivation of the histaminergic system in AD at central and peripheral levels might reflect a neuroimmune reaction to brain tissue damage, a neurotrophic response, and/or a reactive process to regulate the IL-1 induced amyloid precursor protein (APP) overproduction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
January 1985, Lancet (London, England),
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
October 1991, Biological psychiatry,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
September 1983, The British journal of psychiatry : the journal of mental science,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
July 1993, Acta neurologica Scandinavica,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
August 1994, Medizinische Monatsschrift fur Pharmazeuten,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
April 1995, Journal of geriatric psychiatry and neurology,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
November 2001, Mechanisms of ageing and development,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
March 1997, International journal of geriatric psychiatry,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
January 1988, VASA. Supplementum,
R Cacabelos, and L Fernández-Novoa, and J M Pérez-Trullén, and A Franco-Maside, and X A Alvarez
January 1987, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Copied contents to your clipboard!